痴呆患者共病与多重用药:基于大规模初级保健数据的横断面分析
该研究分析英国314家全科诊所中291169名65岁及以上注册者,其中10258人有电子记录的痴呆诊断。控制年龄和性别后,痴呆患者平均躯体疾病数(2.9 vs 2.4)和重复处方数(5.4 vs 4.2)均高于非痴呆者,且更可能有≥5种躯体疾病、≥5种或≥10种重复处方。
要点
- 痴呆患者平均躯体共病数高于非痴呆者(2.9 vs 2.4,P<0.001)。
- 痴呆患者平均重复处方数更多(5.4 vs 4.2,P<0.001)。
- 痴呆患者有≥5种躯体疾病、≥5种或≥10种重复处方的风险均升高。
核心结论
- 控制年龄和性别后,痴呆患者的躯体共病负担和多重用药均高于非痴呆者。
- 痴呆患者复杂需求需要全科医生与多学科痴呆专家协同整合应对。
研究设计与样本
- 基于英国314家全科诊所、291169名65岁及以上注册者的横断面初级保健数据分析。
- 其中10258人有电子记录的痴呆诊断,比较有无痴呆者32种躯体疾病数量与重复处方数量的差异。
- 采用年龄-性别标准化率计算躯体共病和多重用药的比值比(OR)。
主要发现
- 控制年龄和性别后,痴呆患者平均躯体疾病数为2.9,非痴呆者为2.4(P<0.001)。
- 痴呆患者平均重复处方数为5.4,非痴呆者为4.2(P<0.001)。
- 痴呆患者有≥5种躯体疾病的年龄-性别标准化OR为1.42(95%CI 1.35–1.50;P<0.001)。
- 痴呆患者有≥5种重复处方的标准化OR为1.46(95%CI 1.40–1.52;P<0.001)。
- 痴呆患者有≥10种重复处方的标准化OR为2.01(95%CI 1.90–2.12;P<0.001)。
临床怎么用
- 在老年医学科评估痴呆患者时,应主动筛查躯体共病和多重用药。
- 对痴呆合并多重用药者,建议全科与多学科痴呆专科协同制定整合管理方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The care of older people with dementia is often complicated by physical comorbidity and polypharmacy, but the extent and patterns of these have not been well described. This paper reports analysis of these factors within a large, cross-sectional primary care data set. METHODS: Data were extracted for 291,169 people aged 65 years or older registered with 314 general practices in the UK, of whom 10,258 had an electronically recorded dementia diagnosis. Differences in the number and type of 32 physical conditions and the number of repeat prescriptions in those with and without dementia were examined. Age–gender standardised rates were used to calculate odds ratios (ORs) of physical comorbidity and polypharmacy. RESULTS: People with dementia, after controlling for age and sex, had on average more physical conditions than controls (mean number of conditions 2.9 versus 2.4; P < 0.001) and were on more repeat medication (mean number of repeats 5.4 versus 4.2; P < 0.001). Those with dementia were more likely to have 5 or more physical conditions (age–sex standardised OR [sOR] 1.42, 95% confidence interval (CI) 1.35–1.50; P < 0.001) and were also more likely to be on 5 or more (sOR 1.46; 95% CI 1.40–1.52; P < 0.001) or 10 or more repeat prescriptions (sOR 2.01; 95% CI 1.90–2.12; P < 0.001). CONCLUSIONS: People with dementia have a higher burden of comorbid physical disease and polypharmacy than those without dementia, even after accounting for age and sex differences. Such complex needs require an integrated response from general health professionals and multidisciplinary dementia specialists.
引用
- Clague F, Mercer SW, McLean G, et al. Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data. Age Ageing. 2017. PMID: 28181629. doi:10.1093/ageing/afw176
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。